Ramaiah Memorial Hospital gets JCI accreditation
The hospital underwent a rigorous on-site survey conducted under JCI's 8th Edition framework, where international expert surveyors evaluated RMH for 15 chapters, 237 standards, and 1,094 measurable elements for its compliance on quality, patient safety and governance.
The hospital was recently recognised as a Comprehensive Stroke Centre by the American Stroke Association and received the Comprehensive Chest Pain Centre Certification by the American Heart Association.
'Receiving JCI accreditation is a validation of our relentless pursuit of excellence in patient care,' said M.R. Jayaram, Chairman, Gokula Education Foundation (Medical). 'JCI accreditation equips hospitals with processes that help drive improvement across various areas,' said Andrew Rosen, Vice President, Joint Commission International.
Nagendra Swamy S.C., Chief Executive – Healthcare Services, GEF (M), said the hospital is now one among the 53 Indian JCI accredited hospitals and 663 JCI accredited hospitals in the world.
The announcement was made during a special ceremony held at the hospital, attended by Union Minister Pralhad Joshi, State Health Minister Dinesh Gundu Rao and MLC M.R. Seetharam among others.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
20 minutes ago
- Time of India
In Gujarat's cities, diets still run on cereals
Gandhinagar: In households in Gujarat's cities, cereals may take up less space in the grocery bill, but they still dominate the dinner plate. A new Union govt report shows that cereals, while accounting for just 3.8% of household spending, supply 35% of total calorie intake in cities. In villages, their role is even more dominant, making up 43% of calorie consumption while accounting for 4.5% of total spending. Cereals also account for a major portion of protein intake for people in Gujarat. These insights come from the Centre's latest "Nutritional Intake in India" report, which tracks food patterns and calorie sources across Indian states. The report reveals that Gujarat has seen a modest improvement in overall nutritional intake over the past 15 years, with urban residents gaining an extra 214 calories per day. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad Between 2009-10 and 2023-24, the average per capita daily calorie intake in Gujarat's urban areas increased from 2,096 to 2,310. In rural regions, the increase was more modest, from 2,046 to 2,105 calories per day. Spending patterns show that food still commands a significant portion of monthly expenses. In 2023-24, people in rural Gujarat spent 49.5% of their total expenditure on food, compared to 43.6% in urban areas. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Apply Now Undo Despite this, cereals continue to be the backbone of both calorie and protein intake. The report highlights the composition of protein sources. In rural Gujarat, 47.3% of protein comes from cereals, 10.6% from pulses, 15% from milk and milk products, 3.6% from eggs, fish, and meat, and 23.5% from other sources. In urban areas, 40.4% of protein comes from cereals, 11.2% from pulses, 16.3% from milk and milk products, 3.6% from animal-based foods, and 28.4% from other items. Nutrition experts say the findings underline Gujarat's continued dependence on cereals, especially in rural areas, despite gradual diversification in urban diets. While the increase in calorie intake is a positive sign, the composition of nutrients remains heavily skewed.
The Hindu
2 hours ago
- The Hindu
Experts call for inclusion of Chronic Kidney Disease in national NCD programme
Hyderabad-based dialysis care network, NephroPlus, has urged policymakers to include Chronic Kidney Disease (CKD) screening in India's flagship National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), as it released a white paper highlighting the rising burden of CKD across India and neighbouring countries. Speaking at a media briefing in Hyderabad on Tuesday, NephroPlus Group CEO Rohit Singh said the findings of the white paper and a large-scale screening initiative make a strong case for integrating CKD testing, particularly serum creatinine and urine albumin-to-creatinine ratio (ACR), into existing government-led screenings for hypertension and diabetes. 'The burden is silent but severe. CKD needs to be part of India's NCD strategy immediately,' he said. The paper is based on data from a kidney health screening campaign conducted in the lead-up to World Kidney Day in March. The campaign spanned 30 locations across India, the Philippines, and Uzbekistan, and covered 12 Indian States. A total of 10,501 persons pledged for kidney health awareness, of whom more than 5,000 underwent free serum creatinine and estimated glomerular filtration rate (eGFR) tests. NephroPlus found that several Indian States reported high prevalence of CKD risk factors. Jharkhand topped the list, followed by Haryana and Uttarakhand, Andhra Pradesh, Bihar, Delhi, Karnataka, Maharashtra, Uttar Pradesh, Telangana, Gujarat and Rajasthan. NephroPlus co-founder Kamal D. Shah stressed the economic and emotional toll of dialysis. 'Dialysis is not just a treatment; it is a lifelong ordeal that drains families physically, emotionally and financially. Our data shows that investing ₹1 in prevention saves ₹10 to ₹15 in future dialysis costs,' he said.
Time of India
3 hours ago
- Time of India
Pharma lobby flags 'cumbersome' export rule, seeks change
New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a demand for changing the centralised no-object certification (NOC) provision for drug exports . The provision, which requires pharma companies to seek an approval from the national regulatory agency of the importing country or an NOC from the Indian regulator for shipments, has resulted in a drop in exports and diverted trade to other nations, industry executives told ET. The issue was raised in a meeting held on Monday at Niti Aayog . "Pharma exports have suffered due to the mismatch or an anomaly in newly introduced regulatory standards by the drug regulatory authority of India," said a person who attended the meeting. In early March, the Drugs Controller General of India (DCGI) updated the export NOC checklist in the wake of events such as the controversy over a Mumbai-based drugmaker allegedly exporting addictive opioid drugs to West African nations such as Ghana and Nigeria. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What the Market May Be Getting Wrong About Nvidia Seeking Alpha Read More Undo However, the stringent norms have started hurting exports, industry insiders said. "Taking approvals from different regulatory bodies has only made the whole process cumbersome," the person cited above said. He noted that medicines are manufactured depending on the patient population construct. Live Events For example, Dolo and other paracetamol tablets are approved in India in strengths of 325mg, 500 mg and 650 mg while in Nigeria, it's approved for a strength of 1,000 mg. To manufacture and export that, Indian drugmakers now require an NOC from Nigerian authorities. The lobby groups have urged the government to review the provision as, according to them, this would divert trade to other nations with less stringent regulations. "Such a condition has imposed an undue burden on Indian exporters, potentially stifling innovation and hindering the export of unapproved/banned products especially for the MSME pharmaceutical sector, which is under tremendous strain with respect to compliance to domestic and international guidelines and trade barriers (tariffs & non-tariffs),' an industry expert said on condition of anonymity. The Niti Aayog had called pharma experts to undertake an analysis of the current state of the industry, to understand the challenges faced by drugmakers and initiatives taken by them to ensure production of safe and effective products. Nikkhil K Masurkar, chief executive of Entod Pharmaceuticals, said the official think tank's call for a quality overhaul is both "timely and necessary." "While India has made remarkable strides as a global pharma hub, maintaining consistent, internationally acceptable quality standards remains a key challenge, especially among MSME companies," he said. "The root of the problem often lies not in intent, but in outdated infrastructure, fragmented regulatory enforcement, and insufficient technical training," Masurkar said. "To produce world-class medicines, we must invest in continuous quality improvement, digitalise compliance systems, and empower our MSME sector with both financial and technical support."
